Anaerobic Power and Muscle Strength in Human Immunodeficiency Virus-Positive Preadolescents

PM and R

Volumn 4, Issue 3, 2012, Pages 171-175

  Ramos, Edwardo ^a   Guttierrez Teissoonniere, Suzanne ^b   Conde, Jose G ^a   Baez Cordova, Jose A ^a   Guzman Villar, Brenda ^a   Lopategui Corsino, Edgar ^c   Frontera, Walter R ^d  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INTER AMERICAN UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANAEROBIC POWER; ARTICLE; BICYCLE ERGOMETER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE CLASSIFICATION; DYNAMOMETER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KNEE; LEG; LEISURE; MALE; METABOLIC CAPACITY; MUSCLE STRENGTH; PILOT STUDY; PLAY; PRIORITY JOURNAL; PUERTO RICO; SCHOOL CHILD; SPORT; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ANAEROBIC THRESHOLD; BLOTTING, WESTERN; CHILD; CROSS-SECTIONAL STUDIES; ERGOMETRY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; MALE; MUSCLE STRENGTH; MUSCLE STRENGTH DYNAMOMETER; MUSCLE, SKELETAL; OXIMETRY;

EID: 84858753626     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2011.11.009     Document Type: Article

References (29)

1. Lee G.M., Gortmaker S.L., McIntosh K., Hughes M.D., Oleske J.M. Quality of life for children and adolescents: Impact of HIV infection and antiretroviral treatment. Pediatrics 2006, 117:273-283.
2. Brown L.K., Lourie K.J., Pao M. Children and adolescents living with HIV and AIDS: A review. J Child Psychol Psychiatry 2000, 41:81-96.
3. Keyser R.E., Peralta L., Cade W.T., Miller S., Anixt J. Functional aerobic impairment in adolescents seropositive for HIV: A quasiexperimental analysis. Arch Phys Med Rehabil 2000, 81:1479-1484.
4. Cade W.T., Peralta L., Keyser R.E. Aerobic capacity in late adolescents infected with HIV and control. Pediatr Rehab 2002, 5:161-169.
5. Miller T.L. A hospital-based exercise program to improve body composition, strength, and abdominal adiposity in 2 HIV-infected children. AIDS Read 2007, 17:450-452.
6. Miller T.L., Somarriba G., Kinnamon D.D., Weinberg G.A., Friedman L.B., Scott G.B. The effect of a structures exercise program on nutrition and fitness outcomes in human immunodeficiency virus-infected children. AIDS Res Hum Retroviruses 2010, 26:313-319.
7. Bar-Or O., Rowland T.W. Pediatric Exercise Medicine: From Physiologic Principles to Health Care Application 2004, 12-18. Human Kinetics, Champaign, IL.
8. Beneke R., Hutler M., Leithauser R.M. Anaerobic performance and metabolism in boys and male adolescents. Eur J Appl Physiol 2007, 101:671-677.
9. Bar-Or O. The Wingate anaerobic test: An update on methodology, reliability and validity. Sports Med 1987, 4:381-394.
10. Hack V., Gross A., Bohm A., Stahl-Hennig C., Droge W. Decrease in phosphocreatine level in skeletal muscle of SIV-infected rhesus macaques correlates with decrease in intracellular glutathione. AIDS Res Human Retroviruses 1997, 13:1089-1092.
11. Takken T., van der Net J., Helders P.J.M. Anaerobic exercise capacity in patients with juvenile-onset idiopathic inflammatory myopathies. Arthritis Rheum 2005, 53:173-177.
12. Takken T., Elst E.F., van der Net J. Pathophysiology factors which determine the exercise intolerance in patients with juvenile dermatomyositis. Curr Rheumatol Rev 2005, 1:91-99.
13. Falk B., Tiktinsky R., Weinstein Y., Constantini N., Martinowitz U. Anaerobic power and muscle strength in young hemophilia patients. Med Sci Sports Exerc 2000, 32:52-57.
14. Kaczor J.J., Ziolkowski W., Popinigis J., Tarnopolsky M.A. Anaerobic and aerobic enzyme activities in human skeletal muscle from children and adults. Pediatr Res 2005, 57:331-335.
15. Sanchez R.S., Canto-Nogues C., Munoz-Fernandez A. Reconstructing the course of HIV-1-associated progressive encephalopathy in children. Med Sci Monit 2002, 8:249-252.
16. Schwartz L., Major E.O. Neural progenitors and HIV-1-associated central nervous system disease in adults and children. Curr HIV Res 2006, 4:319-327.
17. Parker D.L., Carriere L., Hebestreit H., Bar-Or O. Anaerobic exercise and peak muscle power in children with spastic cerebral palsy. Am J Dis Child 1992, 146:1069-1073.
18. Parker D.L., Carriere L., Hebestreit H., Salsberg A., Bar-Or O. Muscle performance and gross motor function of children with cerebral palsy. Dev Med Child Neurol 1993, 35:17-23.
19. Berbrayer D., Ashby P. Reciprocal inhibition in cerebral palsy. Neurology 1990, 40:653-656.
20. Unnithan V.B., Dowling G., Frost B., Volpe Ayub, Bar-Or O. Cocontraction and phasic activity during gait in children with cerebral palsy. Electromyogr Clin Neurophysiol 1996, 36:487-494.
21. Stephens S., Singh-Grewal D., Bar-OR O., et al. Reliability of exercise testing and functional activity questionnaires in children with juvenile arthritis. Arthritis Rheum 2007, 57:1446-1452.
22. Cress M.E., Buchner D.M., Questad K.A., Esselman P.C., deLateur B.J., Schwartz R.S. Continuous-scale physical functional performance in healthy older adults: A validation study. Arch Phys Med Rehabil 1996, 77:1243-1250.
23. Slade J.M., Miszko T.A., Laity J.H., Agrawal S.K., Cress M.E. Anaerobic power and physical function in strength in strength-trained and non-strength-trained older adults. J Gerentol 2002, 57A:M168-M172.
24. Miszko T.A., Cress M.E., Slade J.M., Covey C.J., Agrawal S.K., Doerr C.E. Effect of strength and power training on physical function in community-dwelling older adults. J Gerentol 2003, 58A:171-175.
25. Desai V.G., Lee T., Moland C.L., et al. Effect of short-term exposure to zidovudine (AZT) on the expression of mitochondria-related genes in skeletal muscle of neonatal mice. Mitochondrion 2009, 9:9-16.
26. Viengchareun S., Caron M., Auclair M., et al. Mitochondrial toxicity of indinavir, stavudine and zidovudine involves multiple cellular targets in white and brown adipocytes. Antivir Ther 2007, 12:919-929.
27. Cupler E.J., Danon M.J., Jay C., Hench K., Ropka M., Dalakas M.C. Early features of zidovudine-associated myopathy: Histopathological findings and clinical correlations. Acta Neuropathol 1995, 90:1-6.
28. Simpson D.M., Citak K.A., Godfrey E., Godbold J., Wolfe D.E. Myopathies associated with human immunodeficiency virus and zidovudine: Can their effects be distinguished?. Neurology 1993, 43:971-976.
29. Chalmers A.C., Greco C.M., Miller R.G. Prognosis in AZT myopathy. Neurology 1991, 41:1181-1184.